Part D results
CMS's year-end Part D reconciliation, 2022–2024. When a plan's actual drug costs land well above its bid, CMS shares the loss through risk sharing (the "risk corridors"); when they land well below, the plan pays CMS back. A large positive amount means the plan's drug bid was badly underpriced. 2024 is the latest year CMS has published.
How to read this
Risk sharing: positive = CMS paid the plan (costs ran over the bid by more than the corridor); negative = the plan paid CMS. These are CMS's settled figures. Plans also report risk sharing in their MLR filings, sometimes as an estimate made before CMS settled, so a filing can differ.
Per member per year: risk sharing ÷ Part D member-months × 12. Part D member-months include stand-alone drug plan (PDP) members.
CMS's reconciliation also settles reinsurance (catastrophic drug costs) and low-income cost sharing; those are pass-through subsidies, not a sign of profit or loss, so they're shown on contract pages only.
| 2024 | 2023 | 2022 | 3-year total | Per member per year2024 | Part D members2024 avg | |
|---|---|---|---|---|---|---|
| H1035 Florida Blue HMO | $9.8M | $876K | $1.8M | $12.6M | $111 | 88,307 |
| H5774 Triple S Advantage | −$3.9M | −$717K | $6.4M | $1.8M | −$33 | 118,133 |
| R3332 Florida Blue | $0 | −$76.2K | $1.6M | $1.5M | $0 | 19,168 |
| H5938 Capital Health Plan | $989K | −$201K | $92.9K | $881K | $41 | 23,917 |
| H4005 Triple-S Advantage | $51.0K | −$94.5K | $66.2K | $22.7K | $9 | 5,993 |
| H5434 Florida Blue | $3.3M | −$2.4M | −$1.4M | −$442K | $44 | 75,713 |
| S5904 Florida Blue PDP | $1.4M | −$2.4M | −$204K | −$1.2M | $30 | 47,632 |
Red = CMS paid the plan. Sorted by the 3-year total. Parent totals add up each contract under its current parent; CMS also publishes its own parent rollup, which can differ where contracts changed hands.